Isotopes of gallium

Last updated

Isotopes of gallium  (31Ga)
Main isotopes [1] Decay
Isotope abun­dance half-life (t1/2) mode pro­duct
66Ga synth 9.304 h β+ 66Zn
67Gasynth3.2617 d ε 67Zn
68Gasynth67.84 minβ+ 68Zn
69Ga60.1% stable
70Gasynth21.14 min β 70Ge
ε 70Zn
71Ga39.9%stable
72Gasynth14.025 hβ 72Ge
73Gasynth4.86 hβ 73Ge
Standard atomic weight Ar°(Ga)

Natural gallium (31Ga) consists of a mixture of two stable isotopes: gallium-69 and gallium-71. Synthetic radioisotopes are known with atomic masses ranging from 60 to 89, along with seven nuclear isomers. Most of the isotopes with atomic mass numbers below 69 decay by electron capture and positron emission to isotopes of zinc, while most of the isotopes with masses above 71 beta decay to isotopes of germanium.

Contents

The medically important radioisotopes are gallium-67 and gallium-68, used for imaging, and further described below.

List of isotopes


Nuclide
[n 1]
Z N Isotopic mass (Da) [4]
[n 2] [n 3]
Half-life [1]
Decay
mode
[1]
[n 4]
Daughter
isotope

[n 5]
Spin and
parity [1]
[n 6] [n 7]
Natural abundance (mole fraction)
Excitation energyNormal proportion [1] Range of variation
59Ga3128
60Ga312959.95750(22)#72.4(17) ms β+ (98.4%)60Zn(2+)
β+, p (1.6%)59Cu
β+, α? (<0.023%)56Ni
61Ga313060.949399(41)165.9(25) msβ+61Zn3/2−
β+, p? (<0.25%)60Cu
62Ga313161.94418964(68)116.122(21) msβ+62Zn0+
63Ga313262.9392942(14)32.4(5) sβ+63Zn3/2−
64Ga313363.9368404(15)2.627(12) minβ+64Zn0(+#)
64mGa42.85(8) keV21.9(7) μsIT64Ga(2+)
65Ga313464.93273442(85)15.133(28) minβ+65Zn3/2−
66Ga313565.9315898(12)9.304(8) hβ+66Zn0+
67Ga [n 8] 313666.9282023(13)3.2617(4) d EC 67Zn3/2−
68Ga [n 8] 313767.9279802(15)67.842(16) minβ+68Zn1+
69Ga313868.9255735(13)Stable3/2−0.60108(50)
70Ga313969.9260219(13)21.14(5) minβ (99.59%)70Ge1+
EC (0.41%)70Zn
71Ga314070.92470255(87)Stable3/2−0.39892(50)
72Ga314171.92636745(88)14.025(10) hβ72Ge3−
72mGa119.66(5) keV39.68(13) ms IT 72Ga(0+)
73Ga314272.9251747(18)4.86(3) hβ73Ge1/2−
73mGa0.15(9) keV<200 msIT?73Ga3/2−
β73Ge
74Ga314373.9269457(32)8.12(12) minβ74Ge(3−)
74mGa59.571(14) keV9.5(10) sIT (>75%)74Ga(0)(+#)
β? (<25%)74Ge
75Ga314474.92650448(72)126(2) sβ75Ge3/2−
76Ga314575.9288276(21)30.6(6) sβ76Ge2−
77Ga314676.9291543(26)13.2(2) sβ77mGe (88%)3/2−
77Ge (12%)
78Ga314777.9316109(11)5.09(5) sβ78Ge2−
78mGa498.9(5) keV110(3) nsIT78Ga
79Ga314878.9328516(13)2.848(3) sβ (99.911%)79Ge3/2−
β, n (0.089%)78Ge
80Ga314979.9364208(31)1.9(1) sβ (99.14%)80Ge6−
β, n (.86%)79Ge
80mGa [n 9] 22.45(10) keV1.3(2) sβ80Ge3−
β, n?79Ge
IT80Ga
81Ga315080.9381338(35)1.217(5) sβ (87.5%)81mGe5/2−
β, n (12.5%)80Ge
82Ga315181.9431765(26)600(2) msβ (78.8%)82Ge2−
β, n (21.2%)81Ge
β, 2n?80Ge
82mGa140.7(3) keV93.5(67) nsIT82Ga(4−)
83Ga315282.9471203(28)310.0(7) msβ, n (85%)82Ge5/2−#
β (15%)83Ge
β, 2n?81Ge
84Ga315383.952663(32)97.6(12) msβ (55%)84Ge0−#
β, n (43%)83Ge
β, 2n (1.6%)82Ge
85Ga315484.957333(40)95.3(10) msβ, n (77%)84Ge(5/2−)
β (22%)85Ge
β, 2n (1.3%)83Ge
86Ga315585.96376(43)#49(2) msβ, n (69%)85Ge
β, 2n (16.2%)84Ge
β (15%)86Ge
87Ga315686.96901(54)#29(4) msβ, n (81%)86Ge5/2−#
β, 2n (10.2%)85Ge
β (9%)87Ge
88Ga [5] 315787.97596(54)#β?88Ge
β, n?87Ge
89Ga [5] 3158
This table header & footer:
  1. mGa  Excited nuclear isomer.
  2. ()  Uncertainty (1σ) is given in concise form in parentheses after the corresponding last digits.
  3. #  Atomic mass marked #: value and uncertainty derived not from purely experimental data, but at least partly from trends from the Mass Surface (TMS).
  4. Modes of decay:
    EC: Electron capture
    IT: Isomeric transition
    n: Neutron emission
    p: Proton emission
  5. Bold symbol as daughter  Daughter product is stable.
  6. () spin value  Indicates spin with weak assignment arguments.
  7. #  Values marked # are not purely derived from experimental data, but at least partly from trends of neighboring nuclides (TNN).
  8. 1 2 Medical radioisotope used in imaging
  9. Order of ground state and isomer is uncertain.

Gallium-67

Gallium-67 (67
Ga
), the longest-lived radioactive isotope of gallium with a half-life of 3.2617 days, decays by electron capture with gamma emission to stable zinc-67. It is a radiopharmaceutical used in gallium scans (as is gallium-68). This isotope is imaged by a gamma camera.

It is usually used as the free ion, Ga3+.

Gallium-68

Gallium-68 (68
Ga
) is a positron emitter with a half-life of 67.84 minutes, decaying to stable zinc-68. It is used as a radiopharmaceutical, generated in situ from the electron capture of germanium-68 (half-life 271.05 days) owing to its short half-life. The isotope, where a cyclotron is available, can be made in greater quantities by proton bombardment of 68Zn. [6] [7] This positron-emitting isotope can be imaged efficiently by PET scan: see gallium scan. Gallium-68 is normally used as a radioactive label for a ligand which binds to certain tissues, such as DOTATOC and DOTATATE, [8] which are somatostatin analogues useful for imaging neuroendocrine tumors, which gives it a different tissue uptake specificity from the free ion gallium-67 is usually used as. Such scans are useful in locating neuroendocrine tumors and pancreatic cancer. [9] Thus, octreotide scanning for NET tumors (using indium-111) is being increasingly replaced by gallium-68 DOTATOC scan. [10]

See also

Daughter products other than gallium

References

  1. 1 2 3 4 5 Kondev, F. G.; Wang, M.; Huang, W. J.; Naimi, S.; Audi, G. (2021). "The NUBASE2020 evaluation of nuclear properties" (PDF). Chinese Physics C. 45 (3) 030001. doi:10.1088/1674-1137/abddae.
  2. "Standard Atomic Weights: Gallium". CIAAW. 1987.
  3. Prohaska, Thomas; Irrgeher, Johanna; Benefield, Jacqueline; Böhlke, John K.; Chesson, Lesley A.; Coplen, Tyler B.; Ding, Tiping; Dunn, Philip J. H.; Gröning, Manfred; Holden, Norman E.; Meijer, Harro A. J. (2022-05-04). "Standard atomic weights of the elements 2021 (IUPAC Technical Report)". Pure and Applied Chemistry. doi:10.1515/pac-2019-0603. ISSN   1365-3075.
  4. Wang, Meng; Huang, W.J.; Kondev, F.G.; Audi, G.; Naimi, S. (2021). "The AME 2020 atomic mass evaluation (II). Tables, graphs and references*". Chinese Physics C. 45 (3) 030003. doi:10.1088/1674-1137/abddaf.
  5. 1 2 Shimizu, Y.; Kubo, T.; Sumikama, T.; Fukuda, N.; Takeda, H.; Suzuki, H.; Ahn, D. S.; Inabe, N.; Kusaka, K.; Ohtake, M.; Yanagisawa, Y.; Yoshida, K.; Ichikawa, Y.; Isobe, T.; Otsu, H.; Sato, H.; Sonoda, T.; Murai, D.; Iwasa, N.; Imai, N.; Hirayama, Y.; Jeong, S. C.; Kimura, S.; Miyatake, H.; Mukai, M.; Kim, D. G.; Kim, E.; Yagi, A. (8 April 2024). "Production of new neutron-rich isotopes near the N = 60 isotones Ge 92 and As 93 by in-flight fission of a 345 MeV/nucleon U 238 beam". Physical Review C. 109 (4) 044313. doi:10.1103/PhysRevC.109.044313.
  6. Kumlin, J; Dam, J; Langkjaer, N; Chua, C.J.; Borjian, S.; Kassaian, A; Hook, B; Zeisler, S; Schaffer, P; Helge, Thisgaard (October 2019). "Multi-Curie Production of Ga-68 on a Biomedical Cyclotron". Conference: EANM'19. Retrieved 13 December 2019.
  7. Thisgaard, Helge; Kumlin, Joel; Langkjær, Niels; Chua, Jansen; Hook, Brian; Jensen, Mikael; Kassaian, Amir; Zeisler, Stefan; Borjian, Sogol; Cross, Michael; Schaffer, Paul (2021-01-07). "Multi-curie production of gallium-68 on a biomedical cyclotron and automated radiolabelling of PSMA-11 and DOTATATE". EJNMMI Radiopharmacy and Chemistry. 6 (1): 1. doi: 10.1186/s41181-020-00114-9 . ISSN   2365-421X. PMC   7790954 . PMID   33411034.
  8. Chauhan, Aman; El-Khouli, Riham; Waits, Timothy; Agrawal, Rohitashva; Siddiqui, Fariha; Tarter, Zachary; Horn, Millicent; Weiss, Heidi; Oates, Elizabeth; Evers, B. Mark; Anthony, Lowell (2020-08-11). "Post FDA approval analysis of 200 gallium-68 DOTATATE imaging: A retrospective analysis in neuroendocrine tumor patients". Oncotarget. 11 (32): 3061–3068. doi:10.18632/oncotarget.27695. ISSN   1949-2553. PMC   7429177 . PMID   32850010.
  9. Hofman, M.S.; Kong, G.; Neels, O.C.; Eu, P.; Hong, E.; Hicks, R.J. (2012). "High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours". Journal of Medical Imaging and Radiation Oncology. 56 (1): 40–47. doi: 10.1111/j.1754-9485.2011.02327.x . PMID   22339744. S2CID   21843609.
  10. Scott, A, et al. (2018). "Management of Small Bowel Neuroendocrine Tumors". Journal of Oncology Practice. 14 (8): 471–482. doi:10.1200/JOP.18.00135. PMC   6091496 . PMID   30096273.